Novartis shares soar as first-quarter profits beat forecasts
Novartis shares have shot up this morning as the Swiss drugs giant posted better-than-expected earnings for the first quarter.
Read MoreAuthor: Kevin Grogan
Vernalis gets 18.4 million euro cash boost from Paul Capital
The UK’s Vernalis has received a vital cash injection from equity fund Paul Capital Healthcare which will help the firm recover from the financial crisis caused by the rejection last year by US regulators of a supplementary filing for the migraine drug Frova.
Read MoreRoche buys UK biotechnology firm Piramed for $175 million
Roche has hit the acquisition trail again and is buying privately-owned UK biotechnology company Piramed in a deal worth $175 million.
Read MoreAstraZeneca soars as Nexium patent row with Ranbaxy is settled
Investors are reacting positively to the news that AstraZeneca has reached an agreement with Ranbaxy and settled a patent lawsuit in the USA concerning the Anglo-Swedish firm’s blockbuster antiulcerant Nexium.
Read MoreLung cancer warning points to the end for inhaled insulin
The days seem to be numbered for inhaled insulin after Pfizer updated the labelling on its no-longer marketed Exubera product to include a warning relating to lung cancer.
Read More
